documents: FDA-2012-N-0902-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2012-N-0902-0002 | FDA | FDA-2012-N-0902 | Withdrawal of Approvals of New Animal Drug Applications: Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin | Notice | Letter | 2012-09-10T04:00:00Z | 2012 | 9 | 2012-09-10T04:00:00Z | 2012-10-17T20:10:16Z | 2012-22195 | 0 | 0 | 090000648110eb54 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref